Status:
COMPLETED
MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Renal Transplantation
Eligibility:
All Genders
55+ years
Phase:
NA
Brief Summary
Part 1 of the study is to gradually withdraw steroids in a group of 50 older renal transplant recipients, converting then from the 3 drug regimen to a 2 drug regimen (cyclosporine and MMF), while care...
Eligibility Criteria
Inclusion
- Patient who have received a kidney transplant during the "MMF era"
- Patients who have stable graft function indicated by a serum creatinine of \< 1.8 mg/dl, or a calculated creatinine clearance of \> 50 ml/minute
Exclusion
- Patients who have had \> 1 rejection episode,
- Patients who have had a rejection episode within the past year;
- Patients who are steroid dependent due to pre-existing disease (for example, RA or SLE
Key Trial Info
Start Date :
May 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00214279
Start Date
May 1 2002
End Date
November 1 2007
Last Update
June 26 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unversity of Wisconsin
Madison, Wisconsin, United States, 53792